Improving PrEP prescribing in community health centers using predictive analytics
Official title: Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing in Community Health Centers (PrEDICT)
Funded at Harvard Pilgrim Health Care, INC. · NIH-10923913 · Data updated 2026-11-12
This study is working to make it easier for Black and Latino/a/x individuals at risk for HIV to get information and access to a preventive medication called PrEP, by helping doctors identify who might benefit from it and encouraging conversations about sexual health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Pilgrim Health Care, INC. NIH-funded |
| Lab location | 1 site (Canton, UNITED STATES) |
| Project start | September 6, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $643,511 |
| NIH project number | 5R01MH133515-02 |
| Project ID | NIH-10923913 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Black, Latino/a/x, and uninsured individuals who are at increased risk for HIV and may benefit from PrEP.
✕Less likely to help
Patients who are not at risk for HIV or those who are already receiving effective HIV prevention measures may not benefit from this research.
What this research studies
This research aims to enhance the prescribing of pre-exposure prophylaxis (PrEP) for HIV prevention among underserved populations, particularly Black and Latino/a/x individuals. By utilizing predictive analytics and machine learning on electronic health records, the project seeks to identify patients at high risk for HIV and facilitate discussions about PrEP with healthcare providers. The study will involve community health centers, where providers often face challenges in recognizing suitable candidates for PrEP and discussing sexual health. The goal is to create decision support tools that can help overcome these barriers and improve patient access to PrEP.
Why it matters
Potential benefit: If successful, this research could significantly increase the uptake of PrEP among high-risk populations, thereby reducing new HIV infections.
How similar studies have gone: Previous research has shown success in using electronic health records and machine learning to identify at-risk patients for HIV, indicating a promising approach for this project.
Where this research is happening
-
Harvard Pilgrim Health Care, INC.
Canton, United States Active
Researchers
- Principal investigator: Marcus, Julia L. — Harvard Pilgrim Health Care, INC.
- Study coordinator: Marcus, Julia L.
Related research
Other NIH-funded projects on the same topics.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
-
Participatory system dynamics to improve PrEP access in the Bronx
A community-driven project in the Bronx will use system dynamics to identify practical ways to help people at risk for HIV start and stay on PrEP.
-
TB PrEP: Bringing HIV prevention to households affected by TB in Uganda
Aims to help people in households with TB in Uganda access HIV PrEP as part of a combined prevention approach.
-
CARES: A practical program to help adolescent girls and young women use PrEP in Africa
A program called CARES helps young women in South Africa and Zimbabwe use different PrEP options better, with counseling, reminders, and options for support.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.